Cargando…
Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption
Inflammatory bowel diseases (IBDs) are chronic inflammatory gastrointestinal disorders caused by a dysregulated mucosal immune response and epithelial barrier disruption. Conventional treatment of IBD is currently limited to overcoming patient symptoms and is often associated with severe adverse eff...
Autores principales: | Wang, Xuewei, Fan, Fugang, Cao, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940073/ https://www.ncbi.nlm.nih.gov/pubmed/27278299 http://dx.doi.org/10.3892/mmr.2016.5358 |
Ejemplares similares
-
Pulsatilla decoction alleviates colitis by enhancing autophagy and regulating PI3K-Akt-mTORC1 signaling pathway
por: Wang, Xuewei, et al.
Publicado: (2022) -
Therapeutic efficacy and mechanism of water-soluble extracts of Banxiaxiexin decoction on BALB/c mice with oxazolone-induced colitis
por: WANG, XUEWEI, et al.
Publicado: (2014) -
Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway
por: Huangfu, Shaohua, et al.
Publicado: (2020) -
Pulsatilla decoction suppresses matrix metalloproteinase-7-mediated leukocyte recruitment in dextran sulfate sodium-induced colitis mouse model
por: Lin, Ming-Kuem, et al.
Publicado: (2022) -
Pulsatilla in Inflammation of the Testis
por: Lydston, G. Frank
Publicado: (1882)